البحث | Pikumil

Rutuja Deshmukh أضاف وظيفة جديدة أخرى
2026-09-22 09:20:52 -

GLP-1 Agonists Weight Loss Drugs Market Growth as Tirzepatide Gains Momentum
The weight management industry is moving through a major shift as pharmaceutical treatments become an increasingly visible part of obesity care. GLP-1-based medicines have moved from being primarily associated with metabolic disease management to becoming a major category within weight loss treatment, supported by rising obesity prevalence, clinical efficacy, greater awareness, and expanding...

0 التعليقات 0 المشاركات 16 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Rutuja Deshmukh أضاف وظيفة جديدة أخرى
2026-07-24 10:52:46 -

GLP-1 Agonists Weight Loss Drugs Market Supply Chain Analysis
The global GLP-1 Agonists Weight Loss Drugs Market was valued at USD 13.8 billion in 2024 and is projected to grow from USD 27.5 billion in 2026 to USD 48.8 billion by 2030, registering a CAGR of 18.5% from 2025 to 2030. North America dominated the market with a 75.5% revenue share in 2024, supported by high obesity prevalence, favorable reimbursement policies, strong pharmaceutical...

0 التعليقات 0 المشاركات 458 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!